Proposed Study on 340B Drug Pricing for Medicaid

The Frame

What this does

The study aimed to determine if Florida could lower Medicaid drug costs by requiring manufacturers and distributors to offer 340B program discounts to Medicaid pharmacies, potentially changing how pharmacies are reimbursed for covered drugs.

Who is mentioned in the record

Potentially affected actors named in the source documents. Mention is not a position.

Medicaid pharmacies

The bill would have regulated the prices they pay for drugs and the reimbursement they receive from pharmacy benefits managers.

Drug manufacturers

The bill would have required them to sell drugs at 340B prices to Medicaid pharmacies and potentially pay rebates to the state.

Pharmacy benefits managers

The bill would have required them to pay Medicaid pharmacies the 340B discounted price plus a professional dispensing fee.

Drug wholesalers and distributors

The bill would have required them to sell drugs at 340B prices and prohibited them from altering pricing models to exclude these drugs.

What changed

Last recorded activity March 13, 2026.

What's next

Introduced.

Summary

This bill would have required the Florida Agency for Health Care Administration to study the feasibility of mandating discounted 340B drug pricing for Medicaid pharmacies. The study was intended to evaluate how such pricing models would impact drug manufacturers, wholesalers, and .

Key Facts

You don't have to trust us. Each fact below is taken straight from the official document - click any one to see the exact passage, highlighted in the original.

Frequently Asked Questions

What was the goal of this bill?

The bill sought to study whether Florida could mandate that drug manufacturers and wholesalers offer 340B program discounts to Medicaid pharmacies to potentially lower costs.

Did this bill become law?

No, the bill died in the Health Policy committee on March 13, 2026.

Who would have been affected by these changes?

If implemented, the changes would have affected drug manufacturers, wholesalers, , and Medicaid pharmacies.

Why It Matters

The study aimed to determine if Florida could lower Medicaid drug costs by requiring manufacturers and distributors to offer 340B program discounts to Medicaid pharmacies, potentially changing how pharmacies are reimbursed for covered drugs.